New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK

Many different aberrations in the Anaplastic Lymphoma Kinase (ALK) were found to be oncogenic drivers in several cancers including neuroblastoma (NB), therefore ALK is now considered a critical player in NB oncogenesis and a promising therapeutic target. The ALK-inhibitor crizotinib has a limited ac...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Di Paolo, Daniela, Yang, D., Pastorino, Fabio, Emionite, Laura, Cilli, Michele, Daga, Antonio, Destefanis, Elisa, Di Fiore, Annarita, Piaggio, Francesca, Brignole, Chiara, Xu, Xiaobao, Liang, Chris, Gibbons, James, Ponzoni, Mirco, Perri, Patrizia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745691/
https://ncbi.nlm.nih.gov/pubmed/26299615
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia